Home » Merck Gets Marketing Approval for Gardasil, Zolinza, Cubicin in Japan
Merck Gets Marketing Approval for Gardasil, Zolinza, Cubicin in Japan
Healthcare giant Merck & Co. Friday said its human papillomavirus vaccine gardasil, anti-cancer drug zolinza and bacterial infections treatment cubicin have been approved by the Japanese health ministry for use in the country.
RTT News
RTT News
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May